Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Grassi

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|November 23, 2006
Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cellsCamille Roucairol, Stéphane Azoulay, Marie-Claire Nevers, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patientsAlain Pruvost, Eugènia Negredo, Henri Benech, et al.
Plos Pathogens|June 28, 2012
Highly efficient prion transmission by blood transfusionOlivier Andréoletti, Claire Litaise, Hugh Simmons, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2005
Biosynthesis of a D-amino acid in peptide linkage by an enzyme from frog skin secretionsAlexander Jilek, Christa Mollay, Christa Tippelt, et al.
The Journal of Biological Chemistry|May 14, 2004
Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrilsNathalie Morel, Stéphanie Simon, Yveline Frobert, et al.
European Journal of Pharmacology|May 20, 2003
Pharmacological properties of peptides derived from an antibody against the tachykinin NK1 receptor for the neuropeptide substance PAnne Wijkhuisen, Sylvie Tymciu, Jacqueline Fischer, et al.
Journal of Immunological Methods|January 4, 2005
An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patientsStéphane Azoulay, Marie-Claire Nevers, Christophe Créminon, et al.
Journal of Immunoassay & Immunochemistry|October 6, 2004
Immuno-quantitative polymerase chain reaction for detection and quantitation of prion proteinStéphanie Gofflot, Moualij Benaïssa El, Danièle Zorzi, et al.
The Journal of Biological Chemistry|July 12, 2008
Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cellsSophie Mouillet-Richard, Noriyuki Nishida, Elodie Pradines, et al.
FEBS Letters|November 3, 2005
The N-terminal cleavage of cellular prion protein in the human brainIsabelle Laffont-Proust, Baptiste A Faucheux, Raymonde Hässig, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|November 23, 2006
Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cellsCamille Roucairol, Stéphane Azoulay, Marie-Claire Nevers, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patientsAlain Pruvost, Eugènia Negredo, Henri Benech, et al.
Plos Pathogens|June 28, 2012
Highly efficient prion transmission by blood transfusionOlivier Andréoletti, Claire Litaise, Hugh Simmons, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2005
Biosynthesis of a D-amino acid in peptide linkage by an enzyme from frog skin secretionsAlexander Jilek, Christa Mollay, Christa Tippelt, et al.
The Journal of Biological Chemistry|May 14, 2004
Selective and efficient immunoprecipitation of the disease-associated form of the prion protein can be mediated by nonspecific interactions between monoclonal antibodies and scrapie-associated fibrilsNathalie Morel, Stéphanie Simon, Yveline Frobert, et al.
European Journal of Pharmacology|May 20, 2003
Pharmacological properties of peptides derived from an antibody against the tachykinin NK1 receptor for the neuropeptide substance PAnne Wijkhuisen, Sylvie Tymciu, Jacqueline Fischer, et al.
Journal of Immunological Methods|January 4, 2005
An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patientsStéphane Azoulay, Marie-Claire Nevers, Christophe Créminon, et al.
Journal of Immunoassay & Immunochemistry|October 6, 2004
Immuno-quantitative polymerase chain reaction for detection and quantitation of prion proteinStéphanie Gofflot, Moualij Benaïssa El, Danièle Zorzi, et al.
The Journal of Biological Chemistry|July 12, 2008
Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cellsSophie Mouillet-Richard, Noriyuki Nishida, Elodie Pradines, et al.
FEBS Letters|November 3, 2005
The N-terminal cleavage of cellular prion protein in the human brainIsabelle Laffont-Proust, Baptiste A Faucheux, Raymonde Hässig, et al.
Pageof 9